col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


183 Results       Page 1

 [1] 
Wiley: Journal of Thrombosis and Haemostasis
  original article Date Title Authors   All Authors
1 [GO] 2024―Jun―28 Microbiota-driven coagulation activation during SARS-CoV-2 infection Swati Sharma, Silvio Antoniak
2 [GO] 2024―May―28 Extracellular histones: a unifying mechanism driving platelet-dependent extracellular vesicle release and thrombus formation in COVID-19 Alicia S. Eustes, Azaj Ahmed, Jagadish Swamy, Gokul Patil, Melissa Jensen, Katina M. Wilson, et al. (+6)
3 [GO] 2024―May―17 ECMO aggravates platelet GPV shedding and δ-granule deficiency in COVID-19-associated acute respiratory distress syndrome Johannes Herrmann, Lukas J. Weiss, Bastian Just, Kristina Mott, Maria Drayss, Judith Kleiss, et al. (+10)
4 [GO] 2024―Mar―18 2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19 Sam Schulman, Donald M. Arnold, Charlotte A. Bradbury, Lisa Broxmeyer, Jean Marie Connors, Anna Falanga, et al. (+13)
5 [GO] 2024―Mar―05 Role of Microbiota-Derived Corisin in Coagulation Activation during SARS-CoV-2 Infection Tatsuki Tsuruga, Hajime Fujimoto, Taro Yasuma, Corina N. D’Alessandro-Gabazza, Masaaki Toda, Toshiyuki Ito, et al. (+11)
6 [GO] 2024―Feb―29 Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: what have we learned? Toshiaki Iba, Jerrold H. Levy, Cheryl L. Maier, Jean M. Connors, Marcel Levi
7 [GO] 2024―Feb―02 Uncertainties about the roles of anticoagulation and microclots in post-acute sequelae of SARS-CoV-2 infection-response to the letter by Kell et al. Jean M. Connors, Robert A.S. Ariëns
8 [GO] 2024―Feb―02 Uncertainties about the roles of anticoagulation and microclots in postacute sequelae of SARS-CoV-2 infection: comment from Kell et al. Douglas B. Kell, M. Asad Khan, Gert Jacobus Laubscher, Etheresia Pretorius
9 [GO] 2023―Oct―04 COVID-19 promotes endothelial dysfunction and thrombogenicity: Role of pro-inflammatory cytokines/SGLT2 pro-oxidant pathway Ali Mroueh, Walaa Fakih, Adrien Carmona, Antonin Trimaille, Kensuke Matsushita, Benjamin Marchandot, et al. (+15)
10 [GO] 2023―Sep―23 NETs induce persistent lung tissue damage via thromboinflammation without altering virus resolution in a mouse coronavirus model Manuel Salzmann, Patrizia Gibler, Patrick Haider, Mira Brekalo, Roberto Plasenzotti, Thomas Filip, et al. (+7)
11 [GO] 2023―Aug―07 Characterization of all small RNAs in and comparisons across cultured megakaryocytes and platelets of healthy individuals and COVID-19 patients Stepan Nersisyan, Emilie Montenont, Phillipe Loher, Elizabeth A. Middleton, Robert Campbell, Paul Bray, Isidore Rigoutsos
12 [GO] 2023―Jul―25 Uncertainties about the Roles of Anticoagulation and Microclots in Post-acute Sequelae of SARS-CoV-2 Infection Jean M. Connors, Robert A.S. Ariëns
13 [GO] 2023―Jul―17 A commentary on “Thromboinflammation in long COVID - the elusive key to post-infection sequelae?” Toshiaki Iba, Jerrold H. Levy
14 [GO] 2023―Jul―08 Thrombosis, major bleeding, and survival in COVID-19 supported by VV- ECMO in the first vs second wave- multicentre observational study in the UK. Deepa J. Arachchillage, Anna Weatherill, Indika Rajakaruna, Mihaela Gaspar, Zain Odho, Graziella Isgro, et al. (+9)
15 [GO] 2023―Jun―01 Thrombotic Complications in Children with COVID-19 and MIS-C Riten Kumar, Michael J. Rivkin, Leslie Raffini
16 [GO] 2023―May―23 A RANDOMISED CONTROLLED TRIAL TO INVESTIGATE THE USE OF ACUTE CORONARY SYNDROME THERAPY IN PATIENTS HOSPITALISED WITH COVID-19: THE C19-ACS TRIAL Prapa Kanagaratnam, Darrel P. Francis, Daniel Chamie, Clare Coyle, Alena Marynina, George Katritsis, et al. (+34)
17 [GO] 2023―May―13 COVID-19 outcomes in persons with hemophilia: results from a US-based national COVID-19 surveillance registry Anjali Sharathkumar, Linder Wendt, Chris Ortman, Ragha Srinivasan, Christopher Chute, Elizabeth Chrischilles, Clifford Takemoto
18 [GO] 2023―May―11 Thrombo-inflammation in Long COVID - the elusive key to post-infection sequelae? Leo Nicolai, Rainer Kaiser, Konstantin Stark
19 [GO] 2023―Apr―11 NETosis induction reflects COVID-19 severity and Long COVID: insights from a two-center patient cohort study in Israel Nitzan Krinsky, Sofia Sizikov, Sivan Nissim, Adi Dror, Anna Sas, Hodaya Prinz, et al. (+17)
20 [GO] 2023―Mar―12 Distinct platelet crosstalk with adaptive and innate immune cells after adenoviral and mRNA vaccination against SARS-CoV-2. Ludovica Lombardi, Francesca Maiorca, Ramona Marrapodi, Annamaria Sabetta, Noemi Scafa, Davide Pallucci, et al. (+10)
21 [GO] 2023―Feb―28 “Thromboinflammation in COVID-19: can α2-macroglobulin help to control the fire?”: Comment from Seitz et al. Rainer Seitz, Lutz Gürtler, Wolfgang Schramm
22 [GO] 2023―Jan―28 Alterations in platelet proteome signature and impaired platelet integrin αIIbβ3 activation in patients with COVID-19 Lucy J. Goudswaard, Christopher M. Williams, Jawad Khalil, Kate L. Burley, Fergus Hamilton, David Arnold, et al. (+7)
23 [GO] 2023―Jan―25 Peripheral blood mononuclear cell tissue factor (F3 gene) transcript levels and circulating extracellular vesicles are elevated in severe COVID-19 disease Thomas J. Girard, Lilian Antunes Heck, Nan Zhang, Junedh M. Amrute, Renumathi Subramanian, Irem Eldem, et al. (+7)
24 [GO] 2022―Oct―22 “ ISTH guidelines for antithrombotic treatment in COVID-19”: Reply Sam Schulman, Michelle Sholzberg, Alex C. Spyropoulos, Ryan Zarychanski
25 [GO] 2022―Aug―25 Most impactful COVID-19 articles in the field of thrombosis and hemostasis literature Eyal Klang, Gili Kenet, Sarina Levy-Mendelovich
26 [GO] 2022―Aug―15 “Unconventional CD147 -dependent platelet activation elicited by SARS-CoV -2 in COVID -19”: Comment from Wada et al Hideo Wada, Katsuya Shiraki, Katsue Suzuki-Inoue
27 [GO] 2022―Aug―15 “Unconventional CD147 -dependent platelet activation elicited by SARS-CoV -2 in COVID -19”: Reply Norma Maugeri, Angelo A. Manfredi
28 [GO] 2022―Jul―25 Sustained VWF-ADAMTS13 axis imbalance and endotheliopathy in Long COVID syndrome is related to immune dysfunction Helen Fogarty, Soracha E. Ward, Liam Townsend, Ellie Karampini, Stephanie Elliott, Niall Conlon, et al. (+17)
29 [GO] 2022―Jun―27 Commentary on “Risk of venous thromboembolism after COVID-19 vaccination” Corinne Frere, Joe-Elie Salem
30 [GO] 2022―May―21 The thrombosis and haemostasis community network come face-to-face in a new (almost) post pandemic world Beverley Hunt, Robert A. S. Ariëns
31 [GO] 2022―May―05 Refractory immune TTP following Pfizer-BioNTech COVID-19 vaccine successfully salvaged with caplacizumab Eva Laverdure, Catherine Sperlich, Susan Fox
32 [GO] 2022―Apr―10 Risk of Venous Thromboembolism after COVID-19 Vaccination Damon E. Houghton, Waldemar Wysokinski, Ana I. Casanegra, Leslie J. Padrnos, Surbhi Shah, Ewa Wysokinska, et al. (+6)
33 [GO] 2022―Mar―22 Altered fibrin network structure and fibrinolysis in intensive care unit patients with COVID-19, not entirely explaining the increased risk of thrombosis Judith J. de Vries, Chantal Visser, Lotte Geers, Johan A. Slotman, Nadine D. van Kleef, Coen Maas, et al. (+9)
34 [GO] 2022―Mar―22 Bleeding risk of intramuscular injection of COVID-19 vaccines in adult patients with therapeutic anticoagulation Nicolas Gendron, Lina Khider, Christine Le Beller, Benjamin Espinasse, Claire Auditeau, Wafa Amara, et al. (+12)
35 [GO] 2022―Mar―21 Real world, single centre experience of SARS-CoV-2 vaccination in Immune Thrombocytopenia Philippa Woolley, Anish Tailor, Raakhee Shah, John-Paul Westwood, Marie Scully
36 [GO] 2022―Feb―27 Scientific method and the COVID pandemic David Lillicrap, James H. Morrissey
37 [GO] 2022―Feb―17 Shining a Light on Platelet Activation in COVID-19 Frederik Denorme, Abigail Ajanel, Robert A. Campbell
38 [GO] 2022―Feb―14 Platelet size as a mirror for the immune response after SARS-CoV-2 vaccination Thomas Thiele, Silas L. Schwarz, Stefan Handtke
39 [GO] 2022―Feb―12 Thrombosis pathways in COVID-19 versus influenza-associated ARDS: a targeted proteomics approach Emma Rademaker, Dennis J. Doorduijn, Nuray Kusadasi, Coen Maas, Julia Drylewicz, Albert Huisman, et al. (+5)
40 [GO] 2022―Feb―02 Investigating potential mechanisms underlying FVIII inhibition in acquired hemophilia A associated with mRNA COVID-19 vaccines Julia R. Hirsiger, Maria Martinez, Dimitrios A. Tsakiris, Micol G. Cittone, Lukas Graf, Johannes Oldenburg, et al. (+5)
41 [GO] 2022―Feb―01 Non-severe COVID-19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis Sarah Kelliher, Luisa Weiss, Sarah Cullivan, Ellen O’Rourke, Claire A. Murphy, Shane Toolan, et al. (+12)
42 [GO] 2022―Jan―15 Impact of COVID-19 on thrombus composition and response to thrombolysis: Insights from a monocentric cohort population of COVID-19 patients with acute ischemic stroke Jean-Philippe Desilles, Mialitiana Solo Nomenjanahary, Arturo Consoli, Véronique Ollivier, Dorothée Faille, Marie-Charlotte Bourrienne, et al. (+12)
43 [GO] 2022―Jan―15 Platelet and immune signature associated with a rapid response to the BNT162b2 mRNA Covid-19 Vaccine Davide Flego, Simone Cesaroni, Giulio F. Romiti, Bernadette Corica, Ramona Marrapodi, Noemi Scafa, et al. (+12)
44 [GO] 2021―Dec―31 The COVID-19 vaccine ChAdOx1-S is not contaminated with sulfated glycosaminoglycans Susanne Alban, Sandesh Neupane, Ulrich Girreser, Frank D. Sönnichsen, Andreas Greinacher
45 [GO] 2021―Nov―19 COVID-19 - Two years in David Lillicrap, James H. Morrissey
46 [GO] 2021―Nov―09 Antibody-mediated procoagulant platelet formation in COVID-19 is AKT dependent Lisann Pelzl, Anurag Singh, Jonas Funk, Andreas Witzemann, Irene Marini, Jan Zlamal, et al. (+6)
47 [GO] 2021―Nov―05 More on Persistent Endotheliopathy in the Pathogenesis of Long COVID Syndrome Helen Fogarty, Ellie Karampini, Andrew S. O’Donnell, Soracha E. Ward, Jamie M O’Sullivan, James S. O’Donnell
48 [GO] 2021―Nov―03 Persistent Endotheliopathy in the Pathogenesis of Long COVID Syndrome: COMMENT from von Meijenfeldt et al. Fien A. von Meijenfeldt, Sebastian Havervall, Jelle Adelmeijer, Charlotte Thalin, Ton Lisman
49 [GO] 2021―Oct―28 Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 Norma Maugeri, Rebecca De Lorenzo, Nicola Clementi, Roberta Antonia Diotti, Elena Criscuolo, Cosmo Godino, et al. (+7)
50 [GO] 2021―Oct―21 Role of neutrophils, platelets and extracellular vesicles and their interactions in Covid-19-associated thrombopathy Antoine Caillon, Antonin Trimaille, Julie Favre, Laurence Jesel, Olivier Morel, Gilles Kauffenstein
51 [GO] 2021―Sep―19 Use of Novel Antithrombotic Agents for COVID-19: Systemic Summary of Ongoing Randomized Controlled Trials Azita H. Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, Hessam Kakavand, Hamid Ariannejad, Jean M. Connors, et al. (+10)
52 [GO] 2021―Sep―19 Pathology of lung-specific thrombosis and inflammation in COVID-19 Rafael R. Khismatullin, Anastasia A. Ponomareva, Chandrasekaran Nagaswami, Rozalina A. Ivaeva, Kathleen T. Montone, John W. Weisel, Rustem I. Litvinov
53 [GO] 2021―Sep―19 Platelets Contribute to Disease Severity in COVID-19 Tessa J. Barrett, Seda Bilaloglu, Macintosh Cornwell, Hannah M Burgess, Vitor W Virginio, Kamelia Drenkova, et al. (+16)
54 [GO] 2021―Aug―29 Association of Pre-Hospital Antiplatelet Therapy with Survival in Patients Hospitalized with COVID-19: A Propensity Score-Matched Analysis Jonathan H. Chow, Ying Yin, David P. Yamane, Danielle Davison, Ryan Keneally, Katrina Hawkins, et al. (+6)
55 [GO] 2021―Aug―26 Impact of the COVID-19 pandemic on education and clinical training Muntadhar Al Moosawi, Aaron Iding, Paul Armstrong, Thita Chiasakul, Robert Campbell, Caterina Casari, et al. (+13)
56 [GO] 2021―Aug―21 Tissue factor expression, extracellular vesicles and thrombosis after infection with the respiratory viruses influenza A virus and coronavirus Nigel Mackman, Steven P Grover, Silvio Antoniak
57 [GO] 2021―Aug―12 Education of healthcare professionals and the public about thrombosis and COVID-19 Beverley Hunt
58 [GO] 2021―Aug―10 Comparison of adverse drug reactions among four COVID-19 vaccines in Europe using the EudraVigilance database: thrombosis at unusual sites Maria Abbattista, Ida Martinelli, Flora Peyvandi
59 [GO] 2021―Aug―10 Persistent Endotheliopathy in the Pathogenesis of Long COVID Syndrome Helen Fogarty, Liam Townsend, Hannah Morrin, Azaz Ahmad, Claire Comerford, Ellie Karampini, et al. (+17)
60 [GO] 2021―Jul―31 Reply to the letter entitled “Suggested treatment of serious complications to Covid-19 vaccination with IdeS, a bacterial antibody-cleaving enzyme” Yves Gruel, Caroline Vayne, Jérôme Rollin, Claire Pouplard
61 [GO] 2021―Jul―27 Laboratory testing for post ChAdOx1 nCOV-19 vaccination VITT: A challenge. Comment on: Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: Communication from the ISTH SSC Subcommittee on Platelet Immunology Kobe Vercruysse, Katrien M. J. Devreese
62 [GO] 2021―Jul―17 Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine: COMMENT: COMMENT from Gruel et al.: RESPONSE from Kahn et al. Fredrik Kahn, Oongh Shannon, Lars Björck
63 [GO] 2021―Jul―14 The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19 Ang Li, Nicole M. Kuderer, Chih-Yuan Hsu, Yu Shyr, Jeremy L. Warner, Dimpy P. Shah, et al. (+31)
64 [GO] 2021―Jul―14 Physician Experiences in Management of COVID-19-Associated Coagulopathy in Pregnancy: Communication from the ISTH SSC Subcommittee on Women's Health Issues in Thrombosis and Haemostasis Stefan D. Jevtic, A. Kinga Malinowski, Maha Othman, Rezan A Abdul Kadir
65 [GO] 2021―Jul―09 Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19 Anne Hollerbach, Nadine Müller-Calleja, Denise Pedrosa, Antje Canisius, Martin F. Sprinzl, Tanja Falter, et al. (+13)
66 [GO] 2021―Jul―09 Remote history of VTE is associated with severe COVID-19 in middle and older age: UK Biobank cohort study Jana J Anderson, Frederick K Ho, Claire L Niedzwiedz, S. Vittal Katikireddi, Carlos Celis-Morales, Stamatina Iliodromiti, et al. (+13)
67 [GO] 2021―Jul―08 Tissue Factor upregulation is associated with SARS-CoV-2 in the lungs of COVID-19 patients Sandeep Subrahmanian, Alain Borczuk, Steven Salvatore, Kar-Ming Fung, Joan T. Merrill, Jeffrey Laurence, Jasimuddin Ahamed
68 [GO] 2021―Jul―08 Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID-19: a multi-center, open-label, randomized controlled trial Usha S. Perepu, Isaac Chambers, Abdul Wahab, Patrick Ten Eyck, Chaorong Wu, Sanjana Dayal, et al. (+4)
69 [GO] 2021―Jul―05 Imbalanced of von Willebrand factor and ADAMTS13 axis is rather a biomarker of strong inflammation and endothelial damage than a cause of thrombotic process in critically-ill COVID-19 patients Bérangère S. Joly, Michael Darmon, Charlotte Dekimpe, Thibault Dupont, Guillaume Dumas, Elise Yvin, et al. (+4)
70 [GO] 2021―Jun―24 Suggested treatment of serious complications to Covid-19 vaccination with IdeS, a bacterial antibody-cleaving enzyme Fredrik Kahn, Oonagh Shannon, Lars Björck
71 [GO] 2021―Jun―02 ADAMTS13 regulation of VWF multimer distribution in severe COVID-19 Soracha E. Ward, Helen Fogarty, Ellie Karampini, Michelle Lavin, Sonja Schneppenheim, Rita Dittmer, et al. (+23)
72 [GO] 2021―May―21 Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis Pablo Demelo-Rodriguez, Ana Isabel Farfán-Sedano, José María Pedrajas, Pilar Llamas, Patricia Sigüenza, María Jesús Jaras, et al. (+5)
73 [GO] 2021―May―11 Evaluation of laboratory assays for anti-Platelet Factor 4 antibodies after ChAdOx1 nCOV-19 vaccination Sean Platton, Andrew Bartlett, Peter MacCallum, Mike Makris, Vickie McDonald, Deepak Singh, et al. (+2)
74 [GO] 2021―Apr―28 An observational study to identify the prevalence of thrombocytopenia and anti-PF4/polyanion antibodies in Norwegian health care workers after COVID-19 vaccination Ingvild Hausberg Sørvoll, Kjersti Daae Horvei, Siw Leiknes Ernstsen, Ingvild Jenssen Lægreid, Svetlana Lund, Renathe Henriksen Grønli, et al. (+7)
75 [GO] 2021―Apr―27 Post adenoviral-based COVID-19 vaccines thrombosis: A proposed mechanism Kamran Kadkhoda
76 [GO] 2021―Apr―22 Recommendations for the clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia (VITT) for SARS-CoV-2 infections: Communication from the ISTH SSC Subcommittee on Platelet Immunology. Ishac Nazy, Ulrich J Sachs, Donald M. Arnold, Steven E McKenzie, Phil Choi, Karina Althaus, et al. (+4)
77 [GO] 2021―Apr―21 Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine Rolf Ankerlund Blauenfeldt, Søren Risom Kristensen, Siw Leiknes Ernstsen, Claudia Christina Hilt Kristensen, Claus Ziegler Simonsen, Anne-Mette Hvas
78 [GO] 2021―Apr―21 Antibody-mediated platelet activation in COVID-19: A coincidence or a new mechanism of the dysregulated coagulation system? Karina Althaus, Jan Zlamal, Tamam Bakchoul
79 [GO] 2021―Apr―08 Placental growth factor level in plasma predicts COVID-19 severity and in-hospital mortality David M. Smadja, Aurélien Philippe, Olivier Bory, Nicolas Gendron, Agathe Beauvais, Maxime Gruest, et al. (+22)
80 [GO] 2021―Apr―07 Biomarkers of coagulation, endothelial function and fibrinolysis in critically-ill patients with COVID-19: A single-centre prospective longitudinal study Ganeem K. Juneja, Matthew Castelo, Calvin H. Yeh, Samantha E. Cerroni, Bettina E. Hansen, James E. Chessum, et al. (+11)
81 [GO] 2021―Mar―30 A Case Report of Acquired Haemophilia following COVID-19 Vaccine Mansoor Radwi, Sara Farsi
82 [GO] 2021―Mar―28 Bleeding Risk by Intensity of Anticoagulation in Critically Ill Patients with COVID-19: A Retrospective Cohort Study Rim Halaby, Adam Cuker, Jennifer Yui, Andrew Matthews, Ella Ishaaya, Elizabeth Traxler, et al. (+11)
83 [GO] 2021―Mar―16 Similarities and Perspectives on the two C’s - Cancer and COVID-19 Jecko Thachil, Alok Khorana, Marc Carrier
84 [GO] 2021―Feb―27 Platelet-Activating Immune Complexes Identified in Critically Ill COVID-19 Patients Suspected of Heparin-Induced Thrombocytopenia Ishac Nazy, Stefan D Jevtic, Jane C Moore, Angela Huynh, James W Smith, John G Kelton, Donald M Arnold
85 [GO] 2021―Feb―18 Prolonged elevation of D-dimer Levels in Convalescent COVID-19 patients is Independent of the Acute Phase Response Liam Townsend, Helen Fogarty, Adam Dyer, Ignacio Martin-Loeches, Ciaran Bannan, Parthiban Nadarajan, et al. (+11)
86 [GO] 2021―Feb―07 COVID-19 patients often show high-titer non-platelet-activating anti-PF4/heparin IgG antibodies Justine Brodard, Johanna A. Kremer Hovinga, Pierre Fontana, Jan-Dirk Studt, Yves Gruel, Andreas Greinacher
87 [GO] 2021―Feb―06 Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: A multicenter retrospective study Jun-Ying Li, Hong-Fei Wang, Ping Yin, Di Li, Di-Le Wang, Peng Peng, et al. (+17)
88 [GO] 2020―Dec―31 Thrombotic thrombocytopenic Purpura as the initial Presentation of COVID-19 Marie-Claude Beaulieu, Danny Sebastien Mettelus, Benjamin Rioux-Massé, Michèle Mahone
89 [GO] 2020―Dec―31 Thrombotic thrombocytopenic purpura (TTP) response following COVID-19 infection: implications for the ADAMTS13-von Willebrand factor axis Satish Maharaj, Ruobing Xue, Adam Rojan
90 [GO] 2020―Dec―11 SARS-CoV-2 Associated Coagulopathy And Thromboembolism Prophylaxis In Children: A Single Centre Observational Study Giovanni Del Borrello, Isaac Giraudo, Claudia Bondone, Marco Denina, Silvia Garazzino, Claudia Linari, et al. (+6)
91 [GO] 2020―Nov―24 The ADAMTS13-von Willebrand factor axis in COVID-19 patients Ilaria Mancini, Luciano Baronciani, Andrea Artoni, Paola Colpani, Marina Biganzoli, Giovanna Cozzi, et al. (+10)
92 [GO] 2020―Nov―24 Thromboinflammation in COVID-19: Can α 2 -Macroglobulin Help to Control the Fire? Rainer Seitz, Lutz Gürtler, Wolfgang Schramm
93 [GO] 2020―Nov―21 Vascular neutrophilic inflammation and immunothrombosis distinguish severe COVID-19 from influenza pneumonia Leo Nicolai, Alexander Leunig, Sophia Brambs, Rainer Kaiser, Markus Joppich, Marie Hoffknecht, et al. (+23)
94 [GO] 2020―Oct―29 Is there a role for the ACE2 receptor in SARS-CoV-2 interactions with platelets? Robert A. Campbell, Eric Boilard, Matthew T. Rondina
95 [GO] 2020―Oct―09 COMMENT ON AN ARTICLE: „Coagulopathy in COVID-19“ Omer Ć. Ibrahimagić, Dževdet Smajlović, Zikrija Dostović, Suljo Kunić, Aida Šehanović, Biljana Kojić
96 [GO] 2020―Sep―18 COVID-19 patients exhibit reduced procoagulant platelet responses Frederik Denorme, Bhanu Kanth Manne, Irina Portier, Aaron C. Petrey, Elizabeth A. Middleton, Benjamin T. Kile, et al. (+2)
97 [GO] 2020―Sep―18 Defibrotide in the COVID-19 coagulopathy: What is the timing? Antonio Macciò, Clelia Madeddu, Giovanni Caocci, Sara Oppi, Giorgio La Nasa
98 [GO] 2020―Sep―05 Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration Tobias Tritschler, Marie-Eve Mathieu, Leslie Skeith, Marc Rodger, Saskia Middeldorp, Timothy Brighton, et al. (+28)
99 [GO] 2020―Sep―02 Letter in response to: Coagulation markers are independent predictors of increased oxygen requirements and thrombosis in COVID-19 Pervinder bhogal, Melanie Jensen, George Collins, Oliver Spooner, Levansri Makalanda, Daniel Hart, Ounali Jaffer
100 [GO] 2020―Sep―02 COVID-19 Coagulopathy in Pregnancy: Critical Review, Preliminary Recommendations and ISTH Registry - Communication from the ISTH SSC for Women’s Health Rezan Abdul Kadir, Takao Kobayashi, Toshiaki Iba, Offer Erez, Jecko Thachil, Sajida Kazi, et al. (+2)
101 [GO] 2020―Aug―31 2020 - Year of COVID-19 David Lillicrap, James H. Morrissey
102 [GO] 2020―Aug―29 Response to “Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance and their limitation”: don’t throw the baby out with the bathwater C. Nougier, R. Benoit, Y. Dargaud
103 [GO] 2020―Aug―29 Incidence of Deep Vein Thrombosis among non-ICU Patients Hospitalized for COVID-19 Despite Pharmacological Thromboprophylaxis: Angelo Porfidia, Angelo Santoliquido, Giulia Cammá, Enrica Porceddu, Roberto Pola
104 [GO] 2020―Aug―29 Response to Maccio et al., “Multifactorial Pathogenesis of COVID-19-related Coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?” Edward Richardson, Carmelo Carlo-Stella, Ruben Jara, Israel Vlodavsky, Massimo Iacobelli, Jawed Fareed, et al. (+6)
105 [GO] 2020―Aug―29 Consensus-Based Clinical Recommendations and Research Priorities for Anticoagulant Thromboprophylaxis in Children Hospitalized for COVID-19-Related Illness Neil A. Goldenberg, Anthony Sochet, Manuela Albisetti, Tina Biss, Mariana Bonduel, Julie Jaffray, et al. (+9)
106 [GO] 2020―Aug―28 Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID-19 Antoine Rauch, Julien Labreuche, Fanny Lassalle, Julien Goutay, Morgan Caplan, Leslie Charbonnier, et al. (+11)
107 [GO] 2020―Aug―13 Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance and their limitations Michael Hardy, Jonathan Douxfils, Marion Bareille, Sarah Lessire, Isabelle Gouin-Thibault, Pierre Fontana, et al. (+2)
108 [GO] 2020―Aug―07 Circulating endothelial progenitors are increased in Covid-19 patients and correlate with SARS-CoV-2 RNA in severe cases Patrizia Mancuso, Antonio Gidaro, Giuliana Gregato, Alessandro Raveane, Paola Cremonesi, Jessica Quarna, et al. (+6)
109 [GO] 2020―Aug―07 In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID-19 patients on anticoagulation Annabel Blasi, Fien A. Meijenfeldt, Jelle Adelmeijer, Andrea Calvo, Cristina Ibañez, Juan Perdomo, et al. (+2)
110 [GO] 2020―Aug―07 Is the COVID-19 thrombotic catastrophe complement-connected? Edward M. Conway, Edward L.G. Pryzdial
111 [GO] 2020―Jul―29 Hypoxia - an overlooked trigger for thrombosis in COVID-19 and other critically ill patients Jecko Thachil
112 [GO] 2020―Jul―29 Chronic Therapeutic Anticoagulation is Associated with Decreased Thrombotic Complications in SARS-CoV-2 Infection Daniel J. Lachant, Neil A. Lachant, Peter Kouides, Stephen Rappaport, Paritosh Prasad, R. James White
113 [GO] 2020―Jul―21 Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID-19 Rushad Patell, Thomas Bogue, Poorva Bindal, Anita Koshy, Mwanasha Merrill, William C Aird, et al. (+2)
114 [GO] 2020―Jul―21 Multifactorial pathogenesis of COVID-19-related coagulopathy. Can defibrotide have a role in the early phases of coagulation disorders? Antonio Macciò, Clelia Madeddu, Giovanni Caocci, Giorgio La Nasa
115 [GO] 2020―Jul―21 Fibrinolysis and COVID-19: a tale of two sites? Charithani B. Keragala, Robert L. Medcalf, Paul S. Myles
116 [GO] 2020―Jul―21 The hazard of (sub)therapeutic doses of anticoagulants in non-critically ill patients with Covid-19: the Padua province experience Raffaele Pesavento, Davide Ceccato, Giampaolo Pasquetto, Jacopo Monticelli, Lucia Leone, Annachiara Frigo, et al. (+16)
117 [GO] 2020―Jul―15 Hypofibrinolytic state and high thrombin generation may play a major role in sars-cov2 associated thrombosis Christophe Nougier, Remi Benoit, Marie Simon, Helene Desmurs-Clavel, Guillaume Marcotte, Laurent Argaud, et al. (+4)
118 [GO] 2020―Jul―14 COVID-19-associated coagulopathy - Hypothesis: Are Children protected due to enhanced thrombin inhibition by higher α 2 -Macroglobulin (α2-M)? Wolfgang Schramm, Rainer Seitz, Lutz Gürtler
119 [GO] 2020―Jul―13 ISTH DIC Subcommittee Communication on Anticoagulation in COVID-19 Jecko Thachil, Nicole P. Juffermans, Marco Ranucci, Jean M. Connors, Theodore E. Warkentin, Thomas L. Ortel, et al. (+3)
120 [GO] 2020―Jul―13 Are chilblains a skin expression of COVID-19 microangiopathy? Marie Baeck, Anne Herman, Caroline Peeters, Liliane Marot, Cedric Hermans
121 [GO] 2020―Jul―07 Incidence of Deep Vein Thrombosis among non-ICU Patients Hospitalized for COVID-19 Despite Pharmacological Thromboprophylaxis Angelo Santoliquido, Angelo Porfidia, Antonio Nesci, Giuseppe De Matteis, Giuseppe Marrone, Enrica Porceddu, et al. (+259)
122 [GO] 2020―Jul―03 Specific coagulation markers may provide more therapeutic targets in COVID-19 patients receiving prophylactic anticoagulant Ning Tang, Huan Bai, Dongsheng Xiong, Ziyong Sun
123 [GO] 2020―Jul―03 Antiphospholipid antibodies in patients with COVID-19: a relevant observation? Katrien M.J. Devreese, Eleni A. Linskens, Dominique Benoit, Harlinde Peperstraete
124 [GO] 2020―Jul―03 Living through a pandemic - A time for clarity, courage and truth Claire McLintock
125 [GO] 2020―Jul―01 Response to ‘the association between D-dimer in COVID-19 patients and mortality remains beset of uncertainties’ Litao Zhang, Xinsheng Yan, Yiyao Gong, Zhenlu Zhang
126 [GO] 2020―Jul―01 COVID-19: a collision of complement, coagulation and inflammatory pathways Anoop J. Chauhan, Laura J. Wiffen, Thomas P. Brown
127 [GO] 2020―Jul―01 Lupus anticoagulant is frequent in patients with Covid-19: Response to Reply Inès Harzallah, Agathe Debliquis, Bernard Drénou
128 [GO] 2020―Jun―19 Coagulopathy in COVID-19 Toshiaki Iba, Jerrold H. Levy, Marcel Levi, Jecko Thachil
129 [GO] 2020―Jun―19 Curative anticoagulation prevents endothelial lesion in COVID-19 patients Lina Khider, Nicolas Gendron, Guillaume Goudot, Richard Chocron, Caroline Hauw-Berlemont, Charles Cheng, et al. (+19)
130 [GO] 2020―Jun―16 Fibrinolysis and COVID-19: a plasmin paradox Robert L. Medcalf, Charithani B. Keragala, Paul S. Myles
131 [GO] 2020―Jun―11 Thromboprophylaxis in a patient with COVID-19 and severe hemophilia A on emicizumab prophylaxis María Isabel Rivas-Pollmar, María Teresa Álvarez-Román, Nora V. Butta-Coll, Mónica Martín Salces, Sara García-Barcenilla, Victor Jiménez-Yuste
132 [GO] 2020―Jun―11 Response to ‘all these D-dimers in COVID-19’ Litao Zhang
133 [GO] 2020―Jun―11 The need for accurate D-dimer reporting in COVID-19: Communication from the ISTH SSC on Fibrinolysis Jecko Thachil, Colin Longstaff, Emmanuel J. Favaloro, Giuseppe Lippi, Tetsumei Urano, Paul Y. Kim
134 [GO] 2020―Jun―04 The association between D-dimers in COVID-19 patients and mortality remains beset of uncertainties Jean-Christophe Gris, Paul Loubet, Claire Roger, Eva Cochery-Nouvellon, Jean-Marc Mauboussin, Laurent Muller, et al. (+6)
135 [GO] 2020―Jun―03 Forum article: The protective rather than prothrombotic fibrinogen in COVID-19 and other inflammatory states Jecko Thachil
136 [GO] 2020―May―29 All those D-dimers in COVID-19 Jecko Thachil
137 [GO] 2020―May―29 Frequency of lupus anticoagulant in Covid-19 patients Inès Harzallah, Agathe Debliquis, Bernard Drénou
138 [GO] 2020―May―29 Reply to ‘Ibuprofen and thromboembolism in SARS-COV2’ Songping Cui, Shuo Chen, Lihui Ke
139 [GO] 2020―May―28 Macrothrombosis and stroke in patients with mild Covid-19 infection Michael G. Fara, Laura K. Stein, Maryna Skliut, Susan Morgello, Johanna T. Fifi, Mandip S. Dhamoon
140 [GO] 2020―May―27 Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19 Alex C. Spyropoulos, Jerrold H. Levy, Walter Ageno, Jean Marie Connors, Beverley J Hunt, Toshiaki Iba, et al. (+5)
141 [GO] 2020―May―19 Heparin - an old drug with multiple potential targets in Covid-19 therapy Ulf Lindahl, Jin-Ping Li
142 [GO] 2020―May―16 Ibuprofen and thromboembolism in SARS-COV2 Arian Arjomandi Rad, Robert Vardanyan, Natalie R Tas
143 [GO] 2020―May―14 Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID-19 patients Francisco Sandro Menezes-Rodrigues, José Gustavo Padrão Tavares, Marcelo Pires de Oliveira, Rafael Guzella de Carvalho, Paolo Ruggero Errante, Murched Omar Taha, et al. (+2)
144 [GO] 2020―May―14 Response to “uncertainties on the prognostic value of D-dimers in COVID-19 patients” Litao Zhang
145 [GO] 2020―May―07 Coagulopathy of COVID-19 and antiphospholipid antibodies Nathan T. Connell, Elisabeth M. Battinelli, Jean M. Connors
146 [GO] 2020―May―07 Response to 'What do monitoring platelet counts in COVID-19 teach us?' Xiaobo Yang, You Shang
147 [GO] 2020―May―07 Response to “Lupus anticoagulant is frequent in patients with Covid-19” Ning Tang
148 [GO] 2020―May―05 Incidence of venous thromboembolism in hospitalized patients with COVID-19 Saskia Middeldorp, Michiel Coppens, Thijs F. van Haaps, Merijn Foppen, Alexander P. Vlaar, Marcella C.A. Müller, et al. (+7)
149 [GO] 2020―Apr―29 Hereditary Haemorrhagic Telangiectasia: a disease not to be forgotten during the COVID-19 pandemic Eleonora Gaetani, Giulio Cesare Passali, Maria Elena Riccioni, Annalisa Tortora, Roberto Pola, Guido Costamagna, Antonio Gasbarrini
150 [GO] 2020―Apr―28 Uncertainties on the prognostic value of D-dimers in COVID-19 patients Jean-Christophe Gris, Isabelle Quéré, Antonia Pérez-Martin, Jean-Yves Lefrant, Albert Sotto
151 [GO] 2020―Apr―28 What do monitoring platelet counts in COVID-19 teach us? Jecko Thachil
152 [GO] 2020―Apr―28 DIC in COVID-19: Implications for Prognosis and Treatment? Rainer Seitz, Wolfgang Schramm
153 [GO] 2020―Apr―24 Type and dose of heparin in COVID-19 Jecko Thachil, Ning Tang, Satoshi Gando, Anna Falanga, Marcel Levi, Cary Clark, et al. (+2)
154 [GO] 2020―Apr―24 Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19 Claire S Whyte, Gael B Morrow, Joanne L Mitchell, Pratima Chowdary, Nicola J Mutch
155 [GO] 2020―Apr―24 Direct oral anticoagulant plasma levels striking increase in severe COVID-19 respiratory syndrome patients treated with antiviral agents. The Cremona experience Sophie Testa, Paolo Prandoni, Oriana Paoletti, Rossella Morandini, Maurizio Tala, Claudia Dellanoce, et al. (+5)
156 [GO] 2020―Apr―23 Laboratory haemostasis monitoring in COVID-19 Jecko Thachil, Ning Tang, Satoshi Gando, Anna Falanga, Marcel Levi, Cary Clark, Toshiaki Iba
157 [GO] 2020―Apr―23 Lupus anticoagulant is frequent in patients with Covid-19 Inès Harzallah, Agathe Debliquis, Bernard Drénou
158 [GO] 2020―Apr―22 High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients Jean-François Llitjos, Maxime Leclerc, Camille Chochois, Jean-Michel Monsallier, Michel Ramakers, Malika Auvray, Karim Merouani
159 [GO] 2020―Apr―19 D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19 Litao Zhang, Xinsheng Yan, Qingkun Fan, Haiyan Liu, Xintian Liu, Zejin Liu, Zhenlu Zhang
160 [GO] 2020―Apr―17 Thromboinflammation and the hypercoagulability of COVID-19 Jean M. Connors, Jerrold H. Levy
161 [GO] 2020―Apr―17 RE: ISTH interim guidance to recognition and management of coagulopathy in COVID-19 Satoshi Akima, Claire McLintock, Beverley J Hunt
162 [GO] 2020―Apr―17 Potential of Heparin and Nafamostat Combination Therapy for COVID-19 Hidesaku Asakura, Haruhiko Ogawa
163 [GO] 2020―Apr―17 Thrombocytopenia and Its Association with Mortality in Patients with COVID-19 Xiaobo Yang, Qingyu Yang, Yaxin Wang, Yongran Wu, Jiqian Xu, Yuan Yu, You Shang
164 [GO] 2020―Apr―17 The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome Marco Ranucci, Andrea Ballotta, Umberto Di Dedda, Ekaterina Bayshnikova, Marco Dei Poli, Marco Resta, et al. (+3)
165 [GO] 2020―Apr―17 Hypercoagulability of COVID-19 patients in Intensive Care Unit. A Report of Thromboelastography Findings and other Parameters of Hemostasis Mauro Panigada, Nicola Bottino, Paola Tagliabue, Giacomo Grasselli, Cristina Novembrino, Veena Chantarangkul, et al. (+3)
166 [GO] 2020―Apr―17 ISTH interim guidance on recognition and management of coagulopathy in COVID-19: A Comment Christopher D. Barrett, Hunter B. Moore, Michael B. Yaffe, Ernest E. Moore
167 [GO] 2020―Apr―17 Response to 'Reply to Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy' Ning Tang
168 [GO] 2020―Apr―17 Reply to "Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy" Rubén Coto-Hernández, María Teresa Fábregas Ruano
169 [GO] 2020―Apr―16 COVID-19: 2020 a year in turmoil David Lillicrap, James H. Morrissey
170 [GO] 2020―Apr―15 Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19 Marisa Dolhnikoff, Amaro Nunes Duarte-Neto, Renata Aparecida de Almeida Monteiro, Luiz Fernando Ferraz da Silva, Ellen Pierre de Oliveira, Paulo Hilário Nascimento Saldiva, et al. (+2)
171 [GO] 2020―Apr―15 Impact of the COVID-19 pandemic on therapeutic choices in Thrombosis-Hemostasis C. Hermans, C. Lambert
172 [GO] 2020―Apr―15 Venous thromboembolism in COVID-19 patients Angelo Porfidia, Roberto Pola
173 [GO] 2020―Apr―15 Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia Deepa RJ Arachchillage, Mike Laffan
174 [GO] 2020―Apr―15 Pulmonary thrombosis in 2019-nCoV pneumonia? Francesco Marongiu, Elvira Grandone, Doris Barcellona
175 [GO] 2020―Apr―13 DOACs and ‘newer’ haemophilia therapies in COVID-19 Jecko Thachil, Ning Tang, Satoshi Gando, Anna Falanga, Marco Cattaneo, Marcel Levi, et al. (+2)
176 [GO] 2020―Apr―11 Exploring possible mechanisms for COVID-19 induced thrombocytopenia: Unanswered Questions Ariunzaya Amgalan, Maha Othman
177 [GO] 2020―Apr―09 Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia Songping Cui, Shuo Chen, Xiunan Li, Shi Liu, Feng Wang
178 [GO] 2020―Apr―08 Tissue Plasminogen Activator (tPA) Treatment for COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS): A Case Series Janice Wang, Negin Hajizadeh, Ernest E. Moore, Robert C. McIntyre, Peter K Moore, Livia A. Veress, et al. (+3)
179 [GO] 2020―Apr―02 The versatile heparin in COVID-19 Jecko Thachil
180 [GO] 2020―Mar―27 Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy Ning Tang, Huan Bai, Xing Chen, Jiale Gong, Dengju Li, Ziyong Sun
181 [GO] 2020―Mar―26 ISTH interim guidance on recognition and management of coagulopathy in COVID-19 Jecko Thachil, Ning Tang, Satoshi Gando, Anna Falanga, Marco Cattaneo, Marcel Levi, et al. (+2)
182 [GO] 2020―Mar―25 Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia David Lillicrap
183 [GO] 2020―Feb―19 Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia Ning Tang, Dengju Li, Xiong Wang, Ziyong Sun
 [1] 

183 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec